Detailed information for compound 183508

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 498.551 | Formula: C24H26N4O6S
  • H donors: 2 H acceptors: 6 LogP: 1.4 Rotable bonds: 8
    Rule of 5 violations (Lipinski): 1
  • SMILES: ONC(=O)[C@H]1[C@H](C)N(CCN1S(=O)(=O)c1ccc(cc1)OCc1ccnc2c1cccc2)C(=O)C
  • InChi: 1S/C24H26N4O6S/c1-16-23(24(30)26-31)28(14-13-27(16)17(2)29)35(32,33)20-9-7-19(8-10-20)34-15-18-11-12-25-22-6-4-3-5-21(18)22/h3-12,16,23,31H,13-15H2,1-2H3,(H,26,30)/t16-,23+/m0/s1
  • InChiKey: IINBMMZSLVIMTL-QMHKHESXSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens matrix metallopeptidase 1 (interstitial collagenase) Starlite/ChEMBL References
Homo sapiens matrix metallopeptidase 13 (collagenase 3) Starlite/ChEMBL References
Homo sapiens ADAM metallopeptidase domain 17 Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Echinococcus multilocularis adam 17 protease Get druggable targets OG5_132656 All targets in OG5_132656
Schistosoma japonicum ko:K06059 a disintegrin and metalloproteinase domain 17, putative Get druggable targets OG5_132656 All targets in OG5_132656
Echinococcus granulosus adam 17 protease Get druggable targets OG5_132656 All targets in OG5_132656
Schistosoma mansoni ADAM17 peptidase (M12 family) Get druggable targets OG5_132656 All targets in OG5_132656
Echinococcus multilocularis Blood coagulation inhibitor, Disintegrin Get druggable targets OG5_132656 All targets in OG5_132656
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_132656 All targets in OG5_132656
Echinococcus granulosus Blood coagulation inhibitor Disintegrin Get druggable targets OG5_132656 All targets in OG5_132656
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Echinococcus granulosus matrix metallopeptidase 7 M10 family matrix metallopeptidase 13 (collagenase 3) 471 aa 448 aa 34.1 %
Brugia malayi Disintegrin family protein ADAM metallopeptidase domain 17 824 aa 724 aa 27.4 %
Brugia malayi Matrixin family protein matrix metallopeptidase 1 (interstitial collagenase) 403 aa 401 aa 27.7 %
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Onchocerca volvulus Matrilysin homolog 0.0117 0.1068 1
Brugia malayi metalloprotease disintegrin 16 with thrombospondin type I motif 0.0105 0.0835 0.6517
Echinococcus multilocularis matrix metallopeptidase 7 (M10 family) 0.0191 0.2582 0.7318
Schistosoma mansoni ADAM17 peptidase (M12 family) 0.0223 0.3222 1
Wolbachia endosymbiont of Brugia malayi enoyl-ACP reductase 0.0557 1 0.5
Loa Loa (eye worm) matrixin family protein 0.0127 0.1281 0.1562
Trichomonas vaginalis hypothetical protein 0.0557 1 0.5
Loa Loa (eye worm) matrixin family protein 0.0117 0.1068 0.1302
Schistosoma mansoni ADAMTS5 peptidase (M12 family) 0.0105 0.0835 0.2066
Toxoplasma gondii enoyl-acyl carrier reductase ENR 0.0557 1 0.5
Brugia malayi Hemopexin family protein 0.0075 0.0214 0.1666
Plasmodium falciparum enoyl-acyl carrier reductase 0.0557 1 0.5
Echinococcus multilocularis adam 17 protease 0.0223 0.3222 1
Mycobacterium leprae NADH-DEPENDENT ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE INHA (NADH-DEPENDENT ENOYL-ACP REDUCTASE) 0.0557 1 1
Mycobacterium ulcerans enoyl-(acyl carrier protein) reductase 0.0557 1 1
Mycobacterium tuberculosis NADH-dependent enoyl-[acyl-carrier-protein] reductase InhA (NADH-dependent enoyl-ACP reductase) 0.0557 1 1
Plasmodium vivax enoyl-acyl carrier protein reductase 0.0557 1 0.5
Onchocerca volvulus Matrix metalloproteinase homolog 0.0117 0.1068 1
Echinococcus multilocularis Blood coagulation inhibitor, Disintegrin 0.014 0.1537 0.2942
Brugia malayi Matrixin family protein 0.0127 0.1281 1
Echinococcus granulosus adam 17 protease 0.0245 0.3673 1
Echinococcus granulosus matrix metallopeptidase 7 M10 family 0.0191 0.2582 0.6156
Loa Loa (eye worm) hypothetical protein 0.0468 0.8203 1
Echinococcus granulosus Blood coagulation inhibitor Disintegrin 0.014 0.1537 0.2474

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) nM Compound was tested for the inhibition of human recombinant tumor necrosis factor-alpha converting enzyme catalytic domain was expressed with its prodomain in baculoviral infected insect (SF9) cells; not determined ChEMBL. 12951101
IC50 (binding) 0 nM Compound was tested for the inhibition of human recombinant tumor necrosis factor-alpha converting enzyme catalytic domain was expressed with its prodomain in baculoviral infected insect (SF9) cells; not determined ChEMBL. 12951101
IC50 (binding) = 17 nM In vitro inhibition of matrix metalloprotease-13. ChEMBL. 12951101
IC50 (binding) = 17 nM In vitro inhibition of matrix metalloprotease-13. ChEMBL. 12951101
IC50 (binding) = 830 nM In vitro inhibition of matrix metalloprotease-1. ChEMBL. 12951101
IC50 (binding) = 830 nM In vitro inhibition of matrix metalloprotease-1. ChEMBL. 12951101
IC50 (functional) = 0.3 uM Inhibition of Tumor necrosis factor-alpha (TNF-alpha) release in human whole blood ChEMBL. 12951101
IC50 (functional) = 0.3 uM Inhibition of Tumor necrosis factor-alpha (TNF-alpha) release in human whole blood ChEMBL. 12951101

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.